» Articles » PMID: 15925433

Protection Against Influenza Virus Infection in BALB/c Mice Immunized with a Single Dose of Neuraminidase-expressing DNAs by Electroporation

Overview
Journal Vaccine
Date 2005 Jun 1
PMID 15925433
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of a single dose of plasmid DNA encoding neuraminidase (NA) or hemagglutinin (HA) from influenza virus A/PR/8/34 (PR8) (H1N1) to protect against homologous virus infection was examined in BALB/c mice. In the present study, mice were immunized once with 30 microg of NA or HA DNA by electroporation. Four weeks or 28 weeks after immunization, mice were challenged with a lethal dose of homologous virus and the ability of NA or HA DNA to protect the mice from influenza was evaluated. We found that a single inoculation of NA DNA could provide protection against influenza virus challenge as well as long-term protection against viral infection. Whereas, the mice immunized with a single dose of HA DNA could not be protected. In addition, neonatal mice immunized with a single dose of 30 microg of NA DNA could be provided with significant protection against viral infection.

Citing Articles

Optimizing a linear 'Doggybone' DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen.

Cunliffe R, Stirling D, Razzano I, Murugaiah V, Montomoli E, Kim S Discov Immunol. 2024; 3(1):kyad030.

PMID: 38567290 PMC: 10917164. DOI: 10.1093/discim/kyad030.


Comparative Pathology of Animal Models for Influenza A Virus Infection.

Kirk N, Liang Y, Ly H Pathogens. 2024; 13(1).

PMID: 38251342 PMC: 10820042. DOI: 10.3390/pathogens13010035.


Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.

Werninghaus I, Hinke D, Fossum E, Bogen B, Braathen R Mol Ther. 2023; 31(7):2188-2205.

PMID: 36926694 PMC: 10362400. DOI: 10.1016/j.ymthe.2023.03.012.


Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.

Carascal M, Pavon R, Rivera W Front Immunol. 2022; 13:878943.

PMID: 35663997 PMC: 9162156. DOI: 10.3389/fimmu.2022.878943.


Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program.

Shanko A, Shuklina M, Kovaleva A, Zabrodskaya Y, Vidyaeva I, Shaldzhyan A Vaccines (Basel). 2020; 8(4).

PMID: 33322762 PMC: 7768547. DOI: 10.3390/vaccines8040756.